This compound is a phosphoramidite building block used in oligonucleotide synthesis. It features a long-chain fatty acid ester moiety linked to a protected nucleoside via an ether bridge, along with a cyanoethyl phosphoramidite group for solid-phase DNA/RNA synthesis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2642320-25-8
DMTr-2'-O-C22-rU-3'-CE-Phosphoramidite
pharmaceutical intermediate
2'-O-Hexadecyl-U-CE-Phosphoramidite
pharmaceutical intermediate
5'-O-(4,4-Dimethoxytrityl)-2'-deoxy-2'-fluorouridine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite
pharmaceutical intermediate
(1R,3R,4R,7S)-1-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-(2-(((dimethylamino)methylene)amino)-6-oxo-3H-purin-9(6H)-yl)-2,5-dioxabicyclo[2.2.1]heptan-7-yl (2-cyanoethyl) diisopropylphosphoramidite
pharmaceutical intermediate
2'-O-Propargyl g(iBu)-3'-phosphoramidite
pharmaceutical intermediate
N2-iBu-5'-O-DMTr-2'-O-hexadecanyl guanosine 3'-CED
pharmaceutical intermediate
1-(2,5-Anhydro-4-{[bis(4-methoxyphenyl)(phenyl)methoxy]methyl}-3-O-{(2-cyanoethoxy)[di(propan-2-yl)amino]phosphanyl}-6-deoxy-alpha-L-mannofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione
pharmaceutical intermediate
N-(4-(2,2-Dicyano-1-hydroxyvinyl)benzyl)-5-fluoro-2-methoxybenzamide
pharmaceutical intermediate
methyl 16-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-2-(2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxyhexadecanoate
NWFCOAVWTXVSHI-GWCNJYPESA-N
CC(C)N(C(C)C)P(OCCC#N)O[C@@H]1[C@H](O[C@H]([C@@H]1OCCCCCCCCCCCCCCCC(=O)OC)N2C=CC(=O)NC2=O)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC
—